2.08
+0.084(+4.20%)
Currency In USD
| Previous Close | 2 |
| Open | 2.01 |
| Day High | 2.1 |
| Day Low | 2.01 |
| 52-Week High | 4.66 |
| 52-Week Low | 1.63 |
| Volume | 20,864 |
| Average Volume | 69,457 |
| Market Cap | 10.79M |
| PE | -0.97 |
| EPS | -2.14 |
| Moving Average 50 Days | 2.28 |
| Moving Average 200 Days | 2.35 |
| Change | 0.08 |
If you invested $1000 in BioCardia, Inc. (BCDA) 10 years ago, it would be worth $4.76 as of July 03, 2025 at a share price of $2.084. Whereas If you bought $1000 worth of BioCardia, Inc. (BCDA) shares 5 years ago, it would be worth $19.79 as of July 03, 2025 at a share price of $2.084.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System
GlobeNewswire Inc.
Jun 25, 2025 12:00 PM GMT
SUNNYVALE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Paten
BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025
GlobeNewswire Inc.
May 21, 2025 12:30 PM GMT
SUNNYVALE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that BioCardia’s CEO, Peter Altman
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
GlobeNewswire Inc.
May 09, 2025 8:28 PM GMT
SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update